Collaboration to develop and market vision analysis system

Article

Visiometrics and Medeuronet have formed together to develop and market Visiometrics' Optical Quality Analysis System (OQAS).

Visiometrics and Medeuronet have formed together to develop and market Visiometrics' Optical Quality Analysis System (OQAS).

Pan-European strategic commercial partner Medeuronet will market the system, created by Barcelona-based ophthalmic firm Visiometrics. OQAS is based on the works of Dr Pablo Artal, University of Murcia, Spain.

The system is based on the double-pass technique in which the punctual light source's size and shape projected onto the retina is analysed. The analysis will then provide the user with the point spread function (PSF), tear film quality, optical scattering index (OSI) and the modulation transfer function (MTF) of the eye.

Medeuronet aims to educate users on using the system in a clinical environment and how to make use of its benefits. The OQAS can be used to diagnose pathologies and compare pre and post-cataract and refractive surgery measurements and outcomes.

Other features of the OQAS include accommodation on retinal image quality, objective measurement of halos and glare and presenting the impact of higher-order aberrations and light scatter on visual acuity.

Visiometrics' Chief Executive Officer said, "We see this partnership with Medeuronet as a critical next step in the acceptance of OQAS on a wider commercial scale. We know that OQAS is the key tool to accurately and objectively assess the patient's quality of vision."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.